Sinocelltech Group Limited (SHA:688520)
37.05
+1.83 (5.20%)
Sep 30, 2026, 3:00 PM CST
Sinocelltech Group Market Cap
Sinocelltech Group has a market cap or net worth of 17.43 billion as of October 2, 2026. Its market cap has decreased by -29.38% in one year.
Market Cap
17.43B
Enterprise Value
19.18B
Revenue
1.25B
Ranking
n/a
PE Ratio
n/a
Stock Price
37.05
ChartMarket Cap Chart
Since June 22, 2020, Sinocelltech Group's market cap has decreased from 31.81B to 17.43B, a decrease of -45.22%. That is a compound annual growth rate of -9.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 17.43B | -9.65% |
| Dec 31, 2025 | 19.29B | 19.54% |
| Dec 31, 2024 | 16.13B | -32.75% |
| Dec 29, 2023 | 23.99B | -11.11% |
| Dec 30, 2022 | 26.99B | 6.06% |
| Dec 31, 2021 | 25.45B | 28.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evopoint Biosciences | 21.51B |
| Xiamen Amoytop Biotech | 21.02B |
| Hebei Changshan Biochemical Pharmaceutical | 20.33B |
| Sino Biological,Inc. | 19.34B |
| Yili Chuanning Biotechnology | 18.28B |
| HitGen | 17.91B |
| BrightGene Bio-Medical Technology | 15.59B |
| GemPharmatech | 15.52B |